Meeting DSM-5 diagnostic criteria for Generalized Anxiety Disorder;
Having a first episode of Generalized Anxiety Disorder or not having used an anxiolytic, antidepressant, antipsychotic, or anticonvulsant medication in the last 1 month.
Having a Hamilton Anxiety Scale (HAMA) score of more than 14 and a Hamilton Depression Scale (HAMD-17) score of less than 17.
Current or previous diagnosis of other major diseases (e.g., coronary heart disease, pulmonary heart disease, etc.)
Currently or previously diagnosed with a mental disorder other than anxiety disorder (except for insomnia disorder);
Those who are participating or have participated in vagus nerve stimulation therapy; those who are participating in transcranial magnetic stimulation or transcranial direct current therapy;
Pregnant, breastfeeding, or planning to become pregnant during the trial;
Refusing to sign the informed consent form.
Clareo Health | Transcutaneous Vagus Nerve Stimulation for Generalized Anxiety Disorder
